ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Enoxaparin Sodium Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-6L9458
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Enoxaparin Sodium Market Insights and Forecast to 2028
BUY CHAPTERS

Global Enoxaparin Sodium Market Research Report 2024

Code: QYRE-Auto-6L9458
Report
April 2024
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
TEVA
Techdow (Hepalink)
Fresenius Kabi
Rovi
Amphastar
Nanjing King-friend
Apotex
Cipla Ltd
Taj Pharma
Chengdu Baiyu Pharmaceutical
Changzhou Qianhong Bio-pharma
Beijing SL Pharmaceutical
Huadong Medicine
Fosun Pharma (Gland Pharma)
Sandoz(Novartis)

Enoxaparin Sodium Market Size

The global Enoxaparin Sodium market was valued at US$ 3315 million in 2023 and is anticipated to reach US$ 5415 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.

Enoxaparin Sodium Market

Enoxaparin Sodium Market

Enoxaparin sodium is an anticoagulant medication (blood thinner). It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. It is also used during hemodialysis.
The core global manufacturers of enoxaparin sodium include Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi, Rovi and Amphastar. The top three manufacturers account for approximately 66% of the global share. Sanofi is the world's largest manufacturer of enoxaparin sodium, with a market share of approximately 42%.
Europe is the world's largest enoxaparin sodium market, accounting for nearly 60% of the market share. The second and third places are North America and Asia, accounting for 19% and 16% respectively.
In terms of product type, 60 mg/0.6mL occupies a dominant position, accounting for 29% of the market share. At the same time, in terms of sales channels, hospitals and clinics are the main sales channels, accounting for 80%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Enoxaparin Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enoxaparin Sodium.
The Enoxaparin Sodium market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Enoxaparin Sodium market comprehensively. Regional market sizes, concerning products by Type, by Sales Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enoxaparin Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sales Channel, and by regions.

Scope of Enoxaparin Sodium Market Report

Report Metric Details
Report Name Enoxaparin Sodium Market
Accounted market size in 2023 US$ 3315 million
Forecasted market size in 2030 US$ 5415 million
CAGR 7.1%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • 20 mg/0.2mL
  • 30 mg/0.3mL
  • 40 mg/0.4mL
  • 60 mg/0.6mL
  • 80 mg/0.8mL
  • 100 mg/1mL
  • 120 mg/0.8mL
  • 150 mg/1mL
  • 300mg/3mL
Segment by Sales Channel
  • Hospital & Clinic
  • Pharmacy
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, Techdow (Hepalink), Teva, Nanjing King-friend, Rovi, Fresenius Kabi, Fosun Pharma(Gland Pharma), Amphastar, Sandoz (Novartis), Apotex, Huadong Medicine, Cipla, Taj Pharma, Chengdu Baiyu Pharmaceutical, Changzhou Qianhong Bio-pharma, Beijing SL Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Enoxaparin Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Enoxaparin Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Sales Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Enoxaparin Sodium Market growing?

Ans: The Enoxaparin Sodium Market witnessing a CAGR of 7.1% during the forecast period 2024-2030.

What is the Enoxaparin Sodium Market size in 2030?

Ans: The Enoxaparin Sodium Market size in 2030 will be US$ 5415 million.

What is the market share of major companies in Enoxaparin Sodium Market?

Ans: The top three manufacturers account for approximately 66% of the global share.

What is the Sanofi share in Enoxaparin Sodium Market?

Ans: Sanofi is the world's largest manufacturer of enoxaparin sodium, with a market share of approximately 42%.

What is the Enoxaparin Sodium Market share by region?

Ans: Europe is the world's largest enoxaparin sodium market, accounting for nearly 60% of the market share.

What is the Enoxaparin Sodium Market share by type?

Ans: In terms of product type, 60 mg/0.6mL occupies a dominant position, accounting for 29% of the market share.

Who are the main players in the Enoxaparin Sodium Market report?

Ans: The main players in the Enoxaparin Sodium Market are Sanofi, Techdow (Hepalink), Teva, Nanjing King-friend, Rovi, Fresenius Kabi, Fosun Pharma(Gland Pharma), Amphastar, Sandoz (Novartis), Apotex, Huadong Medicine, Cipla, Taj Pharma, Chengdu Baiyu Pharmaceutical, Changzhou Qianhong Bio-pharma, Beijing SL Pharmaceutical

What are the Type segmentation covered in the Enoxaparin Sodium Market report?

Ans: The Types covered in the Enoxaparin Sodium Market report are 20 mg/0.2mL, 30 mg/0.3mL, 40 mg/0.4mL, 60 mg/0.6mL, 80 mg/0.8mL, 100 mg/1mL, 120 mg/0.8mL, 150 mg/1mL, 300mg/3mL

1 Enoxaparin Sodium Market Overview
1.1 Product Definition
1.2 Enoxaparin Sodium by Type
1.2.1 Global Enoxaparin Sodium Market Value Comparison by Type (2024-2030)
1.2.2 20 mg/0.2mL
1.2.3 30 mg/0.3mL
1.2.4 40 mg/0.4mL
1.2.5 60 mg/0.6mL
1.2.6 80 mg/0.8mL
1.2.7 100 mg/1mL
1.2.8 120 mg/0.8mL
1.2.9 150 mg/1mL
1.2.10 300mg/3mL
1.3 Enoxaparin Sodium by Sales Channel
1.3.1 Global Enoxaparin Sodium Market Value by Sales Channel (2024-2030)
1.3.2 Hospital & Clinic
1.3.3 Pharmacy
1.3.4 Others
1.4 Global Enoxaparin Sodium Market Size Estimates and Forecasts
1.4.1 Global Enoxaparin Sodium Revenue 2019-2030
1.4.2 Global Enoxaparin Sodium Sales 2019-2030
1.4.3 Global Enoxaparin Sodium Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Enoxaparin Sodium Market Competition by Manufacturers
2.1 Global Enoxaparin Sodium Sales Market Share by Manufacturers (2019-2024)
2.2 Global Enoxaparin Sodium Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Enoxaparin Sodium Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Enoxaparin Sodium, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Enoxaparin Sodium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Enoxaparin Sodium, Product Type & Application
2.7 Global Key Manufacturers of Enoxaparin Sodium, Date of Enter into This Industry
2.8 Global Enoxaparin Sodium Market Competitive Situation and Trends
2.8.1 Global Enoxaparin Sodium Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Enoxaparin Sodium Players Market Share by Revenue
2.8.3 Global Enoxaparin Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Enoxaparin Sodium Market Scenario by Region
3.1 Global Enoxaparin Sodium Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Enoxaparin Sodium Sales by Region: 2019-2030
3.2.1 Global Enoxaparin Sodium Sales by Region: 2019-2024
3.2.2 Global Enoxaparin Sodium Sales by Region: 2025-2030
3.3 Global Enoxaparin Sodium Revenue by Region: 2019-2030
3.3.1 Global Enoxaparin Sodium Revenue by Region: 2019-2024
3.3.2 Global Enoxaparin Sodium Revenue by Region: 2025-2030
3.4 North America Enoxaparin Sodium Market Facts & Figures by Country
3.4.1 North America Enoxaparin Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Enoxaparin Sodium Sales by Country (2019-2030)
3.4.3 North America Enoxaparin Sodium Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Enoxaparin Sodium Market Facts & Figures by Country
3.5.1 Europe Enoxaparin Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Enoxaparin Sodium Sales by Country (2019-2030)
3.5.3 Europe Enoxaparin Sodium Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Spain
3.6 Asia Pacific Enoxaparin Sodium Market Facts & Figures by Region
3.6.1 Asia Pacific Enoxaparin Sodium Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Enoxaparin Sodium Sales by Region (2019-2030)
3.6.3 Asia Pacific Enoxaparin Sodium Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Southeast Asia
3.7 Latin America Enoxaparin Sodium Market Facts & Figures by Country
3.7.1 Latin America Enoxaparin Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Enoxaparin Sodium Sales by Country (2019-2030)
3.7.3 Latin America Enoxaparin Sodium Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Enoxaparin Sodium Market Facts & Figures by Country
3.8.1 Middle East and Africa Enoxaparin Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Enoxaparin Sodium Sales by Country (2019-2030)
3.8.3 Middle East and Africa Enoxaparin Sodium Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
3.8.7 Eqypt
3.8.8 South Africa
4 Segment by Type
4.1 Global Enoxaparin Sodium Sales by Type (2019-2030)
4.1.1 Global Enoxaparin Sodium Sales by Type (2019-2024)
4.1.2 Global Enoxaparin Sodium Sales by Type (2025-2030)
4.1.3 Global Enoxaparin Sodium Sales Market Share by Type (2019-2030)
4.2 Global Enoxaparin Sodium Revenue by Type (2019-2030)
4.2.1 Global Enoxaparin Sodium Revenue by Type (2019-2024)
4.2.2 Global Enoxaparin Sodium Revenue by Type (2025-2030)
4.2.3 Global Enoxaparin Sodium Revenue Market Share by Type (2019-2030)
4.3 Global Enoxaparin Sodium Price by Type (2019-2030)
5 Segment by Sales Channel
5.1 Global Enoxaparin Sodium Sales by Sales Channel (2019-2030)
5.1.1 Global Enoxaparin Sodium Sales by Sales Channel (2019-2024)
5.1.2 Global Enoxaparin Sodium Sales by Sales Channel (2025-2030)
5.1.3 Global Enoxaparin Sodium Sales Market Share by Sales Channel (2019-2030)
5.2 Global Enoxaparin Sodium Revenue by Sales Channel (2019-2030)
5.2.1 Global Enoxaparin Sodium Revenue by Sales Channel (2019-2024)
5.2.2 Global Enoxaparin Sodium Revenue by Sales Channel (2025-2030)
5.2.3 Global Enoxaparin Sodium Revenue Market Share by Sales Channel (2019-2030)
5.3 Global Enoxaparin Sodium Price by Sales Channel (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Enoxaparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Enoxaparin Sodium Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Techdow (Hepalink)
6.2.1 Techdow (Hepalink) Company Information
6.2.2 Techdow (Hepalink) Description and Business Overview
6.2.3 Techdow (Hepalink) Enoxaparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Techdow (Hepalink) Enoxaparin Sodium Product Portfolio
6.2.5 Techdow (Hepalink) Recent Developments/Updates
6.3 Teva
6.3.1 Teva Company Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Enoxaparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Enoxaparin Sodium Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Nanjing King-friend
6.4.1 Nanjing King-friend Company Information
6.4.2 Nanjing King-friend Description and Business Overview
6.4.3 Nanjing King-friend Enoxaparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nanjing King-friend Enoxaparin Sodium Product Portfolio
6.4.5 Nanjing King-friend Recent Developments/Updates
6.5 Rovi
6.5.1 Rovi Company Information
6.5.2 Rovi Description and Business Overview
6.5.3 Rovi Enoxaparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Rovi Enoxaparin Sodium Product Portfolio
6.5.5 Rovi Recent Developments/Updates
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Company Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Enoxaparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Fresenius Kabi Enoxaparin Sodium Product Portfolio
6.6.5 Fresenius Kabi Recent Developments/Updates
6.7 Fosun Pharma(Gland Pharma)
6.7.1 Fosun Pharma(Gland Pharma) Company Information
6.7.2 Fosun Pharma(Gland Pharma) Description and Business Overview
6.7.3 Fosun Pharma(Gland Pharma) Enoxaparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Fosun Pharma(Gland Pharma) Enoxaparin Sodium Product Portfolio
6.7.5 Fosun Pharma(Gland Pharma) Recent Developments/Updates
6.8 Amphastar
6.8.1 Amphastar Company Information
6.8.2 Amphastar Description and Business Overview
6.8.3 Amphastar Enoxaparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Amphastar Enoxaparin Sodium Product Portfolio
6.8.5 Amphastar Recent Developments/Updates
6.9 Sandoz (Novartis)
6.9.1 Sandoz (Novartis) Company Information
6.9.2 Sandoz (Novartis) Description and Business Overview
6.9.3 Sandoz (Novartis) Enoxaparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sandoz (Novartis) Enoxaparin Sodium Product Portfolio
6.9.5 Sandoz (Novartis) Recent Developments/Updates
6.10 Apotex
6.10.1 Apotex Company Information
6.10.2 Apotex Description and Business Overview
6.10.3 Apotex Enoxaparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Apotex Enoxaparin Sodium Product Portfolio
6.10.5 Apotex Recent Developments/Updates
6.11 Huadong Medicine
6.11.1 Huadong Medicine Company Information
6.11.2 Huadong Medicine Description and Business Overview
6.11.3 Huadong Medicine Enoxaparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Huadong Medicine Enoxaparin Sodium Product Portfolio
6.11.5 Huadong Medicine Recent Developments/Updates
6.12 Cipla
6.12.1 Cipla Company Information
6.12.2 Cipla Description and Business Overview
6.12.3 Cipla Enoxaparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Cipla Enoxaparin Sodium Product Portfolio
6.12.5 Cipla Recent Developments/Updates
6.13 Taj Pharma
6.13.1 Taj Pharma Company Information
6.13.2 Taj Pharma Description and Business Overview
6.13.3 Taj Pharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Taj Pharma Enoxaparin Sodium Product Portfolio
6.13.5 Taj Pharma Recent Developments/Updates
6.14 Chengdu Baiyu Pharmaceutical
6.14.1 Chengdu Baiyu Pharmaceutical Company Information
6.14.2 Chengdu Baiyu Pharmaceutical Description and Business Overview
6.14.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product Portfolio
6.14.5 Chengdu Baiyu Pharmaceutical Recent Developments/Updates
6.15 Changzhou Qianhong Bio-pharma
6.15.1 Changzhou Qianhong Bio-pharma Company Information
6.15.2 Changzhou Qianhong Bio-pharma Description and Business Overview
6.15.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product Portfolio
6.15.5 Changzhou Qianhong Bio-pharma Recent Developments/Updates
6.16 Beijing SL Pharmaceutical
6.16.1 Beijing SL Pharmaceutical Company Information
6.16.2 Beijing SL Pharmaceutical Description and Business Overview
6.16.3 Beijing SL Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Beijing SL Pharmaceutical Enoxaparin Sodium Product Portfolio
6.16.5 Beijing SL Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Enoxaparin Sodium Industry Chain Analysis
7.2 Enoxaparin Sodium Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Enoxaparin Sodium Production Mode & Process
7.4 Enoxaparin Sodium Sales and Marketing
7.4.1 Enoxaparin Sodium Sales Channels
7.4.2 Enoxaparin Sodium Distributors
7.5 Enoxaparin Sodium Customers
8 Enoxaparin Sodium Market Dynamics
8.1 Enoxaparin Sodium Industry Trends
8.2 Enoxaparin Sodium Market Drivers
8.3 Enoxaparin Sodium Market Challenges
8.4 Enoxaparin Sodium Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
TEVA
Techdow (Hepalink)
Fresenius Kabi
Rovi
Amphastar
Nanjing King-friend
Apotex
Cipla Ltd
Taj Pharma
Chengdu Baiyu Pharmaceutical
Changzhou Qianhong Bio-pharma
Beijing SL Pharmaceutical
Huadong Medicine
Fosun Pharma (Gland Pharma)
Sandoz(Novartis)
List of Tables
 Table 1. Global Enoxaparin Sodium Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Enoxaparin Sodium Market Value by Sales Channel (2024-2030) & (US$ Million)
 Table 3. Global Enoxaparin Sodium Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Enoxaparin Sodium Sales (M Units) of Key Manufacturers (2019-2024)
 Table 5. Global Enoxaparin Sodium Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Enoxaparin Sodium Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Enoxaparin Sodium Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Enoxaparin Sodium Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Enoxaparin Sodium, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Enoxaparin Sodium, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Enoxaparin Sodium, Product Type & Application
 Table 12. Global Key Manufacturers of Enoxaparin Sodium, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Enoxaparin Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enoxaparin Sodium as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Enoxaparin Sodium Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Enoxaparin Sodium Sales by Region (2019-2024) & (M Units)
 Table 18. Global Enoxaparin Sodium Sales Market Share by Region (2019-2024)
 Table 19. Global Enoxaparin Sodium Sales by Region (2025-2030) & (M Units)
 Table 20. Global Enoxaparin Sodium Sales Market Share by Region (2025-2030)
 Table 21. Global Enoxaparin Sodium Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Enoxaparin Sodium Revenue Market Share by Region (2019-2024)
 Table 23. Global Enoxaparin Sodium Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Enoxaparin Sodium Revenue Market Share by Region (2025-2030)
 Table 25. North America Enoxaparin Sodium Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Enoxaparin Sodium Sales by Country (2019-2024) & (M Units)
 Table 27. North America Enoxaparin Sodium Sales by Country (2025-2030) & (M Units)
 Table 28. North America Enoxaparin Sodium Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Enoxaparin Sodium Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Enoxaparin Sodium Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Enoxaparin Sodium Sales by Country (2019-2024) & (M Units)
 Table 32. Europe Enoxaparin Sodium Sales by Country (2025-2030) & (M Units)
 Table 33. Europe Enoxaparin Sodium Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Enoxaparin Sodium Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Enoxaparin Sodium Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Enoxaparin Sodium Sales by Region (2019-2024) & (M Units)
 Table 37. Asia Pacific Enoxaparin Sodium Sales by Region (2025-2030) & (M Units)
 Table 38. Asia Pacific Enoxaparin Sodium Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Enoxaparin Sodium Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Enoxaparin Sodium Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Enoxaparin Sodium Sales by Country (2019-2024) & (M Units)
 Table 42. Latin America Enoxaparin Sodium Sales by Country (2025-2030) & (M Units)
 Table 43. Latin America Enoxaparin Sodium Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Enoxaparin Sodium Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Enoxaparin Sodium Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Enoxaparin Sodium Sales by Country (2019-2024) & (M Units)
 Table 47. Middle East and Africa Enoxaparin Sodium Sales by Country (2025-2030) & (M Units)
 Table 48. Middle East and Africa Enoxaparin Sodium Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Enoxaparin Sodium Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Enoxaparin Sodium Sales (M Units) by Type (2019-2024)
 Table 51. Global Enoxaparin Sodium Sales (M Units) by Type (2025-2030)
 Table 52. Global Enoxaparin Sodium Sales Market Share by Type (2019-2024)
 Table 53. Global Enoxaparin Sodium Sales Market Share by Type (2025-2030)
 Table 54. Global Enoxaparin Sodium Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Enoxaparin Sodium Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Enoxaparin Sodium Revenue Market Share by Type (2019-2024)
 Table 57. Global Enoxaparin Sodium Revenue Market Share by Type (2025-2030)
 Table 58. Global Enoxaparin Sodium Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Enoxaparin Sodium Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Enoxaparin Sodium Sales (M Units) by Sales Channel (2019-2024)
 Table 61. Global Enoxaparin Sodium Sales (M Units) by Sales Channel (2025-2030)
 Table 62. Global Enoxaparin Sodium Sales Market Share by Sales Channel (2019-2024)
 Table 63. Global Enoxaparin Sodium Sales Market Share by Sales Channel (2025-2030)
 Table 64. Global Enoxaparin Sodium Revenue (US$ Million) by Sales Channel (2019-2024)
 Table 65. Global Enoxaparin Sodium Revenue (US$ Million) by Sales Channel (2025-2030)
 Table 66. Global Enoxaparin Sodium Revenue Market Share by Sales Channel (2019-2024)
 Table 67. Global Enoxaparin Sodium Revenue Market Share by Sales Channel (2025-2030)
 Table 68. Global Enoxaparin Sodium Price (US$/Unit) by Sales Channel (2019-2024)
 Table 69. Global Enoxaparin Sodium Price (US$/Unit) by Sales Channel (2025-2030)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Sanofi Enoxaparin Sodium Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. Techdow (Hepalink) Company Information
 Table 76. Techdow (Hepalink) Description and Business Overview
 Table 77. Techdow (Hepalink) Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Techdow (Hepalink) Enoxaparin Sodium Product
 Table 79. Techdow (Hepalink) Recent Developments/Updates
 Table 80. Teva Company Information
 Table 81. Teva Description and Business Overview
 Table 82. Teva Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Teva Enoxaparin Sodium Product
 Table 84. Teva Recent Developments/Updates
 Table 85. Nanjing King-friend Company Information
 Table 86. Nanjing King-friend Description and Business Overview
 Table 87. Nanjing King-friend Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Nanjing King-friend Enoxaparin Sodium Product
 Table 89. Nanjing King-friend Recent Developments/Updates
 Table 90. Rovi Company Information
 Table 91. Rovi Description and Business Overview
 Table 92. Rovi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Rovi Enoxaparin Sodium Product
 Table 94. Rovi Recent Developments/Updates
 Table 95. Fresenius Kabi Company Information
 Table 96. Fresenius Kabi Description and Business Overview
 Table 97. Fresenius Kabi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Fresenius Kabi Enoxaparin Sodium Product
 Table 99. Fresenius Kabi Recent Developments/Updates
 Table 100. Fosun Pharma(Gland Pharma) Company Information
 Table 101. Fosun Pharma(Gland Pharma) Description and Business Overview
 Table 102. Fosun Pharma(Gland Pharma) Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Fosun Pharma(Gland Pharma) Enoxaparin Sodium Product
 Table 104. Fosun Pharma(Gland Pharma) Recent Developments/Updates
 Table 105. Amphastar Company Information
 Table 106. Amphastar Description and Business Overview
 Table 107. Amphastar Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Amphastar Enoxaparin Sodium Product
 Table 109. Amphastar Recent Developments/Updates
 Table 110. Sandoz (Novartis) Company Information
 Table 111. Sandoz (Novartis) Description and Business Overview
 Table 112. Sandoz (Novartis) Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Sandoz (Novartis) Enoxaparin Sodium Product
 Table 114. Sandoz (Novartis) Recent Developments/Updates
 Table 115. Apotex Company Information
 Table 116. Apotex Description and Business Overview
 Table 117. Apotex Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Apotex Enoxaparin Sodium Product
 Table 119. Apotex Recent Developments/Updates
 Table 120. Huadong Medicine Company Information
 Table 121. Huadong Medicine Description and Business Overview
 Table 122. Huadong Medicine Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Huadong Medicine Enoxaparin Sodium Product
 Table 124. Huadong Medicine Recent Developments/Updates
 Table 125. Cipla Company Information
 Table 126. Cipla Description and Business Overview
 Table 127. Cipla Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Cipla Enoxaparin Sodium Product
 Table 129. Cipla Recent Developments/Updates
 Table 130. Taj Pharma Company Information
 Table 131. Taj Pharma Description and Business Overview
 Table 132. Taj Pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Taj Pharma Enoxaparin Sodium Product
 Table 134. Taj Pharma Recent Developments/Updates
 Table 135. Chengdu Baiyu Pharmaceutical Company Information
 Table 136. Chengdu Baiyu Pharmaceutical Description and Business Overview
 Table 137. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product
 Table 139. Chengdu Baiyu Pharmaceutical Recent Developments/Updates
 Table 140. Changzhou Qianhong Bio-pharma Company Information
 Table 141. Changzhou Qianhong Bio-pharma Description and Business Overview
 Table 142. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product
 Table 144. Changzhou Qianhong Bio-pharma Recent Developments/Updates
 Table 145. Beijing SL Pharmaceutical Company Information
 Table 146. Beijing SL Pharmaceutical Description and Business Overview
 Table 147. Beijing SL Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 148. Beijing SL Pharmaceutical Enoxaparin Sodium Product
 Table 149. Beijing SL Pharmaceutical Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Enoxaparin Sodium Distributors List
 Table 153. Enoxaparin Sodium Customers List
 Table 154. Enoxaparin Sodium Market Trends
 Table 155. Enoxaparin Sodium Market Drivers
 Table 156. Enoxaparin Sodium Market Challenges
 Table 157. Enoxaparin Sodium Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Enoxaparin Sodium
 Figure 2. Global Enoxaparin Sodium Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Enoxaparin Sodium Market Share by Type: 2023 & 2030
 Figure 4. 20 mg/0.2mL Product Picture
 Figure 5. 30 mg/0.3mL Product Picture
 Figure 6. 40 mg/0.4mL Product Picture
 Figure 7. 60 mg/0.6mL Product Picture
 Figure 8. 80 mg/0.8mL Product Picture
 Figure 9. 100 mg/1mL Product Picture
 Figure 10. 120 mg/0.8mL Product Picture
 Figure 11. 150 mg/1mL Product Picture
 Figure 12. 300mg/3mL Product Picture
 Figure 13. Global Enoxaparin Sodium Market Value by Sales Channel (2024-2030) & (US$ Million)
 Figure 14. Global Enoxaparin Sodium Market Share by Sales Channel: 2023 & 2030
 Figure 15. Hospital & Clinic
 Figure 16. Pharmacy
 Figure 17. Others
 Figure 18. Global Enoxaparin Sodium Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 19. Global Enoxaparin Sodium Market Size (2019-2030) & (US$ Million)
 Figure 20. Global Enoxaparin Sodium Sales (2019-2030) & (M Units)
 Figure 21. Global Enoxaparin Sodium Average Price (US$/Unit) & (2019-2030)
 Figure 22. Enoxaparin Sodium Report Years Considered
 Figure 23. Enoxaparin Sodium Sales Share by Manufacturers in 2023
 Figure 24. Global Enoxaparin Sodium Revenue Share by Manufacturers in 2023
 Figure 25. Global 5 and 10 Largest Enoxaparin Sodium Players: Market Share by Revenue in Enoxaparin Sodium in 2023
 Figure 26. Enoxaparin Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 27. Global Enoxaparin Sodium Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 28. North America Enoxaparin Sodium Sales Market Share by Country (2019-2030)
 Figure 29. North America Enoxaparin Sodium Revenue Market Share by Country (2019-2030)
 Figure 30. United States Enoxaparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Canada Enoxaparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Europe Enoxaparin Sodium Sales Market Share by Country (2019-2030)
 Figure 33. Europe Enoxaparin Sodium Revenue Market Share by Country (2019-2030)
 Figure 34. Germany Enoxaparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. France Enoxaparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. U.K. Enoxaparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Italy Enoxaparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Spain Enoxaparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Asia Pacific Enoxaparin Sodium Sales Market Share by Region (2019-2030)
 Figure 40. Asia Pacific Enoxaparin Sodium Revenue Market Share by Region (2019-2030)
 Figure 41. China Enoxaparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Japan Enoxaparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. South Korea Enoxaparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. India Enoxaparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Australia Enoxaparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Southeast Asia Enoxaparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Latin America Enoxaparin Sodium Sales Market Share by Country (2019-2030)
 Figure 48. Mexico Enoxaparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Brazil Enoxaparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Argentina Enoxaparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Middle East and Africa Enoxaparin Sodium Sales Market Share by Country (2019-2030)
 Figure 52. Middle East and Africa Enoxaparin Sodium Revenue Market Share by Country (2019-2030)
 Figure 53. Turkey Enoxaparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Saudi Arabia Enoxaparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 55. UAE Enoxaparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 56. Eqypt Enoxaparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 57. South Africa Enoxaparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 58. Global Sales Market Share of Enoxaparin Sodium by Type (2019-2030)
 Figure 59. Global Revenue Market Share of Enoxaparin Sodium by Type (2019-2030)
 Figure 60. Global Enoxaparin Sodium Price (US$/Unit) by Type (2019-2030)
 Figure 61. Global Sales Market Share of Enoxaparin Sodium by Sales Channel (2019-2030)
 Figure 62. Global Revenue Market Share of Enoxaparin Sodium by Sales Channel (2019-2030)
 Figure 63. Global Enoxaparin Sodium Price (US$/Unit) by Sales Channel (2019-2030)
 Figure 64. Enoxaparin Sodium Value Chain
 Figure 65. Enoxaparin Sodium Production Process
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions